Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT01741792 · COMPLETED
Trial details
- NCT number
- NCT01741792
- Sponsor
- Amgen Research (Munich) GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.